<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Neurology</journal-id><journal-id journal-id-type="iso-abbrev">Neurology</journal-id><journal-id journal-id-type="pmc-domain-id">798</journal-id><journal-id journal-id-type="pmc-domain">neurology</journal-id><journal-id journal-id-type="publisher-id">neur</journal-id><journal-id journal-id-type="publisher-id">NEUROLOGY</journal-id><journal-title-group><journal-title>Neurology</journal-title></journal-title-group><issn pub-type="ppub">0028-3878</issn><issn pub-type="epub">1526-632X</issn><publisher><publisher-name>American Academy of Neurology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11952700</article-id><article-id pub-id-type="pmcid-ver">PMC11952700.1</article-id><article-id pub-id-type="pmcaid">11952700</article-id><article-id pub-id-type="pmcaiid">11952700</article-id><article-id pub-id-type="pmid">40153684</article-id><article-id pub-id-type="doi">10.1212/WNL.0000000000213511</article-id><article-id pub-id-type="publisher-id">WNL-2024-105691</article-id><article-version-alternatives><article-version article-version-type="pmc-version">1</article-version><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" article-version-type="Version of Record">3</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="hwp-journal-coll"><subject>2</subject><subject>345</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Risk Factors of Aneurysmal Subarachnoid Hemorrhage Including Analysis by Sex</article-title><subtitle>A Systematic Review and Meta-Analysis</subtitle></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3409-7835</contrib-id><name name-style="western"><surname>Ali</surname><given-names initials="M">Mariam</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>van Eldik</surname><given-names initials="MJA">Maaike J.A.</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0004-7830-8248</contrib-id><name name-style="western"><surname>Rietkerken</surname><given-names initials="S">Stijn</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1120-4781</contrib-id><name name-style="western"><surname>Schoones</surname><given-names initials="JW">Jan W.</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2320-0932</contrib-id><name name-style="western"><surname>Kruyt</surname><given-names initials="ND">Nyika D.</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8930-3953</contrib-id><name name-style="western"><surname>Rinkel</surname><given-names initials="GJE">Gabriel J.E.</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6838-9521</contrib-id><name name-style="western"><surname>Wermer</surname><given-names initials="MJH">Marieke J.H.</given-names></name><xref rid="aff4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Peters</surname><given-names initials="S">Sanne</given-names></name><xref rid="aff5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5396-2989</contrib-id><name name-style="western"><surname>Ruigrok</surname><given-names initials="YM">Ynte M.</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><aff id="aff1"><label>1</label>Department of Neurology, Leiden University Medical Center, the Netherlands;</aff><aff id="aff2"><label>2</label>Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, the Netherlands;</aff><aff id="aff3"><label>3</label>Directorate of Research Policy, Leiden University Medical Center, the Netherlands;</aff><aff id="aff4"><label>4</label>Department of Neurology, University Medical Center Groningen, the Netherlands; and</aff><aff id="aff5"><label>5</label>Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht and Utrecht University, the Netherlands.</aff></contrib-group><author-notes><corresp><bold>Correspondence</bold> Dr. Ali <email>m.ali@lumc.nl</email></corresp><fn fn-type="other"><p>The Article Processing Charge was funded by European Research Council.</p></fn><fn fn-type="other"><p>Submitted and externally peer reviewed. The handling editor was Editor-in-Chief Jos&#233; Merino, MD, MPhil, FAAN.</p></fn></author-notes><pub-date pub-type="ppub"><day>22</day><month>4</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>28</day><month>3</month><year>2025</year></pub-date><volume>104</volume><issue>8</issue><issue-id pub-id-type="pmc-issue-id">484675</issue-id><elocation-id>e213511</elocation-id><history><date date-type="received"><day>08</day><month>10</month><year>2024</year></date><date date-type="accepted"><day>28</day><month>1</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>28</day><month>03</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>28</day><month>03</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-03-29 10:25:45.297"><day>29</day><month>03</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2025 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>American Academy of Neurology</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License 4.0 (CCBY)</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="WNL-2024-105691.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="pdf" xlink:href="WNL-2024-105691.pdf"/><abstract><sec><title>Background and Objectives</title><p>A 2005 review identified smoking, hypertension, and excessive alcohol intake as the most important risk factors of aneurysmal subarachnoid hemorrhage (aSAH), but data on other factors remained inconclusive. While aSAH is more prevalent in female participants, evidence on sex differences and female-specific factors remains limited. Comprehensive identification of all risk factors, including potential sex differences and female-specific factors, is essential for improving prevention and accurately assessing aSAH risk. We aimed to determine whether there is now greater certainty around previously inconclusive risk factors, identify any new emerging factors, and explore sex differences in both established and emerging risk factors.</p></sec><sec><title>Methods</title><p>We conducted a systematic review and meta-analysis of cohort and case-control studies on prevalent lifestyle exposures, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. These exposures included smoking, hypertension, alcohol abuse, oral contraception, hormone replacement therapy, hypercholesterolemia, rigorous physical activity, lean body mass index, and diabetes. We calculated pooled sex-specific relative risks (RRs) and odds ratios (ORs) with 95% CIs for overall risk and female-to-male ratios of RRs (RRRs) and ORs (RORs) for sex comparisons.</p></sec><sec><title>Results</title><p>We included 67 studies (34 cohort [8 with sex-specific data], 33 case-control [6 with sex-specific data]; n = 5,743,262; 57% female). A sex-specific association was found for current smoking (RRR 1.53, 95% CI 1.05&#8211;2.23), but not for hypertension (RRR 1.50, 95% CI 0.78&#8211;2.89) or excessive alcohol intake (RRR 0.46, 95% CI 0.13&#8211;1.63). Regular rigorous exercise (RR 0.74, 95% CI 0.53&#8211;1.04; OR 0.69, 95% CI 0.57&#8211;0.83) and diabetes (RR 0.75, 95% CI 0.55&#8211;1.02; OR 0.52, 95% CI 0.41&#8211;0.65) were associated with reduced risk, without sex-specific associations. Data on hypercholesterolemia (RR 1.24, 95% CI 0.97&#8211;1.58; OR 0.52, 95% CI 0.37&#8211;0.74) and lean BMI (RR 1.31, 95% CI 1.15&#8211;1.50; OR 1.39, 95% CI 0.74&#8211;2.60) were inconsistent and showed no sex-specific associations. Hormone replacement therapy (RR 1.03, 95% CI 0.72&#8211;1.48) and oral contraceptive use (RR 5.40, 95% CI 0.68&#8211;42.57) were limited to female patients, with current users compared with never users. Most studies contained potential sources of bias.</p></sec><sec><title>Discussion</title><p>Current smoking, but not hypertension or excessive alcohol, has a stronger association with aSAH in female patients than in male patients. Regular exercise and diabetes are associated with a reduced risk, with no sex-specific associations. Data on female-specific factors remain inconsistent. Targeted smoking prevention may particularly benefit female patients. Large-scale studies are needed to clarify the role of female-specific factors in explaining the higher incidence of aSAH in female patients.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>OPEN-ACCESS</meta-name><meta-value>TRUE</meta-value></custom-meta><custom-meta id="custom-meta-8"><meta-name>SPECIAL-PROPERTY</meta-name><meta-value>CME</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Rupture of an intracranial aneurysm leads to aneurysmal subarachnoid hemorrhage (aSAH), a severe type of stroke with substantial socioeconomic and health care burdens.<sup><xref rid="R1" ref-type="bibr">1</xref></sup> Data suggest that female individuals have 1.61 times higher risk of aSAH than male individuals, although the reasons for this disparity remain unclear.<sup><xref rid="R2" ref-type="bibr">2</xref></sup></p><p>Most aSAH cases are linked to lifestyle factors.<sup><xref rid="R1" ref-type="bibr">1</xref></sup> A 2005 systematic review and meta-analysis identified smoking, hypertension, and excessive alcohol intake as the most important risk factors of aSAH. Data on other risk factors were less conclusive. Hypercholesterolemia (relative risk [RR] of 0.8 [95% CI 0.6&#8211;1.2] in longitudinal studies; odds ratio [OR] of 0.6 [95% CI 0.4&#8211;0.9] in case-control studies) and diabetes (RR 0.3, 95% CI 0&#8211;2.2; OR 0.7, 95% CI 0.5&#8211;0.8) were seemingly associated with a reduced risk while evidence for lean body mass index (BMI) (RR 0.3, 95% CI 0.2&#8211;0.4; OR 1.4, 95% CI 1.0&#8211;2.0) and rigorous exercise (RR 0.5, 95% CI 0.3&#8211;1.0; OR 1.2, 95% CI 1.0&#8211;1.6) was inconsistent.<sup><xref rid="R3" ref-type="bibr">3</xref></sup> Two female-specific factors, hormone replacement therapy and oral contraceptive use, were assessed in female patients only, with current users compared with never and former users combined as the reference group. Hormone replacement therapy was potentially associated with reduced risk (RR 0.6, 95% CI 0.2&#8211;1.5; OR 0.6, 95% CI 0.4&#8211;0.8) while oral contraceptive use did not influence risk (RR 5.4, 95% CI 0.7&#8211;43.5; OR 0.8, 95% CI 0.5&#8211;1.3).<sup><xref rid="R3" ref-type="bibr">3</xref></sup> Recent studies suggest sex-specific differences, particularly for smoking, although results are conflicting.<sup><xref rid="R4" ref-type="bibr">4</xref></sup> Some studies indicate that female individuals who smoke may have a higher risk of aSAH compared with male individuals<sup><xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R6" ref-type="bibr">6</xref></sup> while others report no statistically significant sex differences.<sup><xref rid="R7" ref-type="bibr">7</xref><xref rid="R8" ref-type="bibr">-</xref><xref rid="R9" ref-type="bibr">9</xref></sup></p><p>Given the publication of new research, we aim to provide an updated overview of the clinical risk factors of aSAH, assess whether new data offer more consistent and accurate insights into previously uncertain risk factors, and examine sex differences in both established and newly identified risk factors.</p></sec><sec sec-type="methods" id="s2"><title>Methods</title><p>This systematic review and meta-analysis followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement guidelines and was registered in PROSPERO (ID: CRD42023456329).<sup><xref rid="R10" ref-type="bibr">10</xref></sup> We included all studies from the 2005 meta-analysis and conducted a systematic search in PubMed, Embase, Emcare, Web of Science, and the Cochrane Library (January 2005&#8211;March 2024).<sup><xref rid="R3" ref-type="bibr">3</xref></sup> The search strategy, developed with an expert medical librarian, used terms related to (1) (aneurysmal) subarachnoid hemorrhage, (2) specific (vascular) risk factors, and (3) case-control and prospective cohort studies. Terms excluded case reports, reviews, and non-English studies. References of retrieved and review articles were also screened for additional studies until no further publications were identified. Full search strategy details are available online (eMethods 1 and 2).</p><sec id="s2-1"><title>Selection Criteria</title><p>Inclusion criteria were as follows: (1) prospective cohort or (nested) case-control studies investigating aSAH from saccular aneurysm rupture; (2) provision of crude or adjusted effect estimates with 95% CIs for smoking, hypertension, alcohol use, oral contraceptive use, hormone replacement therapy, hypercholesterolemia, rigorous physical activity, lean BMI, and diabetes, or data allowing for their calculation; (3) overall (for male and female patients combined) or sex-specific data; (4) aSAH diagnosis confirmed by neuroimaging or International Classification of Diseases (ICD) codes; and (5) patients aged 18 years or older; and (6) articles in English (more details available online; eMethods 3). While this article focuses on sex differences, studies historically conflating sex and gender were included, and search terms encompassed both to ensure a comprehensive review.</p></sec><sec id="s2-2"><title>Definition and Classification of Risk Factors</title><p>We largely followed the 2005 meta-analysis,<sup><xref rid="R3" ref-type="bibr">3</xref></sup> with some adjustments: (1) smoking status was categorized as current, former, and ever (current + former), using &#8220;never&#8221; as the reference; (2) for hormone replacement therapy and oral contraceptive use, current, former, and ever users were compared, using never users as the reference. This analysis was limited to female individuals. For the other factors, we use the definitions from the 2005 meta-analysis<sup><xref rid="R3" ref-type="bibr">3</xref></sup>: Alcohol consumption was classified as none, &lt;150 g/wk, and &#8805;150 g/wk (assuming 12 g of ethanol per drink), with &#8220;no alcohol&#8221; as the reference. A lean BMI was defined as &lt;22, with &#8805;22 as the reference. Hypertension (present vs absent), physical activity level (regular rigorous exercise vs no regular rigorous exercise), hypercholesterolemia (vs normal), and diabetes (present vs absent) followed the criteria from the original publications. When studies could not be categorized in line with these definitions, they were included in the systematic review but excluded from the meta-analysis.</p></sec><sec id="s2-3"><title>Study Selection, Data Extraction, and Risk-of-Bias Assessment</title><p>Two independent reviewers (M.A. and M.J.A.v.E.) conducted a two-stage screening process: review of titles and abstracts, followed by review of full-text articles. Data were extracted and recorded using a standardized data extraction form (available online; eMethods 4).</p><p>Quality assessment of the studies was performed with the Newcastle-Ottawa Scale for nonrandomized studies,<sup><xref rid="R11" ref-type="bibr">11</xref></sup> which was adapted for the purpose of our study (details available online; eMethods 5). Disagreements in study selection, data extraction, and risk-of-bias assessment were resolved through consensus meetings involving a third reviewer (Y.M.R.).</p></sec><sec id="s2-4"><title>Statistical Analysis</title><p>For each study, we extracted ORs for case-control studies and RRs, rate ratios, or hazard ratios (HRs) with 95% CIs for cohort studies, or raw patient numbers for each risk factor. For studies with raw patient numbers, we calculated the standard error (SE) to determine the 95% CI using the following formula: SE = &#8730;[(1/a) + (1/b) + (1/c) + (1/d)], where &#8220;a&#8221; and &#8220;b&#8221; are the exposed and unexposed cases and &#8220;c&#8221; and &#8220;d&#8221; are the exposed and unexposed controls. Rate ratios and HRs were interpreted as RRs. We calculated overall estimates (male and female patients combined) and sex-specific estimates when data were available. Female-to-male ratios of RRs (RRRs) and ORs (RORs) were pooled using a random-effects meta-analysis. This approach weighted each estimate by the inverse variance of the log RRs or ORs. The pooled female-to-male ratios were then backtransformed to derive ratios for smoking, hypertension, alcohol use, hypercholesterolemia, physical activity, lean BMI, and diabetes. For female-specific factors, including hormone replacement therapy and oral contraceptive use, only RRs and ORs were calculated. If patients had multiple risk factors, they were included in the analysis of each risk factor. We used the most adjusted estimate available for each risk factor. If adjusted estimates were unavailable, crude effect estimates were pooled together with the adjusted estimates. A random-effects model was used to account for anticipated heterogeneity in patient characteristics and risk factor definitions. Heterogeneity was assessed using Higgins <italic toggle="yes">I</italic><sup>2</sup> statistics, with <italic toggle="yes">I</italic><sup>2</sup> of 25%&#8211;50% being moderate heterogeneity, 50%&#8211;75% substantial, and &gt;75% considerable.<sup><xref rid="R12" ref-type="bibr">12</xref></sup> Separate analyses were conducted for cohort and case-control studies, including forest plots for each risk factor. Funnel plots were used to evaluate publication bias when &gt;10 studies reported on a risk factor (available online; eMethods 6). Statistical analyses were performed using R v.4.3.1.</p></sec><sec id="s2-5"><title>Standard Protocol Approvals, Registrations, and Patient Consents</title><p>Review board approval and informed consent were not required because this research used only published, deidentified data.</p></sec><sec sec-type="data-availability" id="s2-6"><title>Data Availability</title><p>Data not published within the article are available from the corresponding author on reasonable request. The data supplement is available online.</p></sec></sec><sec sec-type="results" id="s3"><title>Results</title><p>In total, 2,969 records were identified from database search. In addition, 37 studies from the previous review were included. In total, 238 studies underwent full-text review. Seventy-one studies met the eligibility criteria (<xref rid="F1" ref-type="fig">Figure 1</xref>),<sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R13" ref-type="bibr">13</xref><xref rid="R14" ref-type="bibr">-</xref><xref rid="R47" ref-type="bibr">47</xref></sup> but 4 were excluded because their reference categories did not align with our predefined categories (available online; eMethods 7).<sup><xref rid="R32" ref-type="bibr">32</xref>,<xref rid="R41" ref-type="bibr">41</xref>,<xref rid="R48" ref-type="bibr">48</xref>,<xref rid="R49" ref-type="bibr">49</xref></sup> Thus, 67 studies (34 longitudinal<sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R27" ref-type="bibr">27</xref><xref rid="R28" ref-type="bibr">-</xref><xref rid="R31" ref-type="bibr">31</xref>,<xref rid="R33" ref-type="bibr">33</xref><xref rid="R34" ref-type="bibr">-</xref><xref rid="R40" ref-type="bibr">40</xref>,<xref rid="R42" ref-type="bibr">42</xref><xref rid="R43" ref-type="bibr">-</xref><xref rid="R47" ref-type="bibr">47</xref>,<xref rid="R50" ref-type="bibr">50</xref>,e1-e11</sup> and 33 case-control studies<sup><xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R13" ref-type="bibr">13</xref><xref rid="R14" ref-type="bibr">-</xref><xref rid="R26" ref-type="bibr">26</xref>,e12-e29</sup>) were included in the meta-analysis<sup><xref rid="R6" ref-type="bibr">6</xref><xref rid="R7" ref-type="bibr">-</xref><xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R13" ref-type="bibr">13</xref><xref rid="R14" ref-type="bibr">-</xref><xref rid="R31" ref-type="bibr">31</xref>,<xref rid="R33" ref-type="bibr">33</xref><xref rid="R34" ref-type="bibr">-</xref><xref rid="R40" ref-type="bibr">40</xref>,<xref rid="R42" ref-type="bibr">42</xref><xref rid="R43" ref-type="bibr">-</xref><xref rid="R47" ref-type="bibr">47</xref>,<xref rid="R50" ref-type="bibr">50</xref>,e1-e29</sup> while the systematic review included 36 longitudinal<sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R27" ref-type="bibr">27</xref><xref rid="R28" ref-type="bibr">-</xref><xref rid="R47" ref-type="bibr">47</xref>,<xref rid="R50" ref-type="bibr">50</xref>,e1-e11</sup> and 35 case-control studies<sup><xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R13" ref-type="bibr">13</xref><xref rid="R14" ref-type="bibr">-</xref><xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R48" ref-type="bibr">48</xref>,<xref rid="R49" ref-type="bibr">49</xref>,e12-e29</sup> (study characteristics summarized in eTables 1 and 2; supplemental references 1&#8211;38 regarding the eTables are available in the supplemental material).</p><fig position="float" id="F1" orientation="portrait"><label>Figure 1</label><caption><title>PRISMA Flow Diagram</title><p>*The search identified 6,962 initial hits, including records for a systematic review on risk factors of unruptured intracranial aneurysms. aSAH = aneurysmal subarachnoid hemorrhage; PRISMA = Preferred Reporting Items for Systematic Reviews and Meta-Analyses.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="WNL-2024-105691f1.jpg"/></fig><p>These 71 studies encompassed 51 unique study populations, with 5,743,262 patients with aSAH (57% female; patient range per study 660&#8211;1,937,360). Forty-seven studies reported data on binary male-female sex (14 with sex-specific data),<sup><xref rid="R6" ref-type="bibr">6</xref><xref rid="R7" ref-type="bibr">-</xref><xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R13" ref-type="bibr">13</xref><xref rid="R14" ref-type="bibr">-</xref><xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R27" ref-type="bibr">27</xref><xref rid="R28" ref-type="bibr">-</xref><xref rid="R31" ref-type="bibr">31</xref>,<xref rid="R33" ref-type="bibr">33</xref>,<xref rid="R34" ref-type="bibr">34</xref>,<xref rid="R36" ref-type="bibr">36</xref>,<xref rid="R37" ref-type="bibr">37</xref>,<xref rid="R39" ref-type="bibr">39</xref>,<xref rid="R42" ref-type="bibr">42</xref>,<xref rid="R44" ref-type="bibr">44</xref><xref rid="R45" ref-type="bibr">-</xref><xref rid="R47" ref-type="bibr">47</xref>,<xref rid="R49" ref-type="bibr">49</xref>,e8,e9,e14-e19,e22-e24,e26-e29</sup> 17 on female-only,<sup><xref rid="R32" ref-type="bibr">32</xref>,<xref rid="R35" ref-type="bibr">35</xref>,<xref rid="R38" ref-type="bibr">38</xref>,<xref rid="R40" ref-type="bibr">40</xref>,<xref rid="R41" ref-type="bibr">41</xref>,<xref rid="R43" ref-type="bibr">43</xref>,<xref rid="R48" ref-type="bibr">48</xref>,e1,e3,e5,e6,e10,e12,e13,e20,e21,e25</sup> and 7 on male-only populations.<sup><xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R50" ref-type="bibr">50</xref>,e2,e4,e7,e11</sup> The age range of participants was 18&#8211;90 years for studies including both sexes, 18&#8211;79 years for female-only studies, and 35&#8211;84 years for male-only studies. The study regions included 24 European, 20 Asian, 15 North American, 4 Oceanian, 3 Latin American, 1 Middle-Eastern, and 4 multicontinental studies (with contributions from Africa, Asia, Europe, and Latin America). Most studies were conducted in high-income countries, several in middle-income countries, and almost none exclusively in low-income countries.</p><sec id="s3-1"><title>Risk-of-Bias Assessment</title><p>The overall quality of the studies varied. Most recruited patients from the general population and provided both crude and adjusted data on risk factors, suggesting a generally lower risk of bias. However, differences in methods for confirming aSAH and assessing risk factors were present: some studies relied on neuroimaging and angiography, classified as low risk of bias, whereas others used less precise methods, such as ICD codes or medical records, which were classified as higher risk of bias. Most studies contained 1 or 2 sources of bias, with only 1 study fulfilling our criteria for high methodological quality (available online; eTables 3 and 4).<sup><xref rid="R38" ref-type="bibr">38</xref></sup> Full results, including funnel plots, are available online (eAppendix 1 and eFigure 1).</p></sec><sec id="s3-2"><title>Meta-Analysis</title><p>Individual forest plots for each risk factor are available in the online (eFigure 2&#8211;16). <xref rid="F2" ref-type="fig">Figure 2</xref> shows the summary forest plots for cohort studies, <xref rid="F3" ref-type="fig">Figure 3</xref> for case-control studies, <xref rid="F4" ref-type="fig">Figure 4</xref> for RRRs, and <xref rid="F5" ref-type="fig">Figure 5</xref> for RORs.</p><fig position="float" id="F2" orientation="portrait"><label>Figure 2</label><caption><title>Summary Forest Plot of Cohort Studies</title><p>BMI = body mass index; N = number of studies; RR = relative risk.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="WNL-2024-105691f2.jpg"/></fig><fig position="float" id="F3" orientation="portrait"><label>Figure 3</label><caption><title>Summary Forest Plot of Case-Control Studies</title><p>BMI = body mass index; N = number of studies; OR = odds ratio.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="WNL-2024-105691f3.jpg"/></fig><fig position="float" id="F4" orientation="portrait"><label>Figure 4</label><caption><title>Summary Forest Plot of Female-to-Male RRRs</title><p>BMI = body mass index; N = number of studies; RRR = ratio of relative risk.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="WNL-2024-105691f4.jpg"/></fig><fig position="float" id="F5" orientation="portrait"><label>Figure 5</label><caption><title>Summary Forest Plot of Female-to-Male RORs</title><p>N = number of studies; ROR = ratio of odds ratio.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="WNL-2024-105691f5.jpg"/></fig><sec id="s3-2-1"><title>Smoking</title><p>Current smoking (vs never) was associated with higher aSAH risk in both cohort studies (pooled RR 2.89, 95% CI 2.43&#8211;3.43, <italic toggle="yes">I</italic><sup>2</sup> = 78%, 20 studies, 3,817,992 patients) and case-control studies (OR 4.25, 95% CI 3.61&#8211;5.01, <italic toggle="yes">I</italic><sup>2</sup> = 21%, 14 studies, 11,979 patients). The association was stronger in female patients compared with male patients (RRR 1.53, 95% CI 1.05&#8211;2.23; <xref rid="T1" ref-type="table">Table 1</xref>). Former smoking was also associated with higher aSAH risk (RR 1.45, 95% CI 1.27&#8211;1.66, <italic toggle="yes">I</italic><sup>2</sup> = 0%, 9 studies, 808,420 patients; OR 1.97, 95% CI 1.22&#8211;3.18, <italic toggle="yes">I</italic><sup>2</sup> = 75%, 9 studies, 5,507 patients), but without a statistically significant sex-specific association (RRR 1.42, 95% CI 0.48&#8211;4.17; ROR 0.31, 95% CI 0.07&#8211;1.35). Ever smoking was assessed only in case-control studies and showed a similar association (OR 3.32, 95% CI 2.07&#8211;5.33, <italic toggle="yes">I</italic><sup>2</sup> = 67%, 4 studies, 2,471 patients).</p><table-wrap position="float" id="T1" orientation="portrait"><label>Table 1</label><caption><p>Effect Sizes of Risk Factors Stratified by Sex and Study Design</p></caption><table frame="hsides" rules="groups"><thead><tr><td rowspan="1" colspan="1">Risk factor</td><td rowspan="1" colspan="1">Female</td><td rowspan="1" colspan="1">Male</td><td rowspan="1" colspan="1">Total<sup><xref rid="tblfn1" ref-type="table-fn">a</xref></sup></td><td rowspan="1" colspan="1">Female-to-male RRRs</td><td rowspan="1" colspan="1">Female-to-male RORs</td></tr></thead><tbody><tr><td rowspan="1" colspan="1">Smoking (vs never)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Cohort studies</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;Current (W: n = 8; M: n = 8)</td><td rowspan="1" colspan="1">3.52 (2.61&#8211;4.75)</td><td rowspan="1" colspan="1">2.31 (1.84&#8211;2.92)</td><td rowspan="1" colspan="1">2.89 (2.43&#8211;3.43)</td><td rowspan="1" colspan="1">1.53 (1.05&#8211;2.23)</td><td rowspan="1" colspan="1">&#8212;</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;Former (W: n = 3; M: n = 3)</td><td rowspan="1" colspan="1">1.56 (0.73&#8211;3.32)</td><td rowspan="1" colspan="1">1.10 (0.51&#8211;2.37)</td><td rowspan="1" colspan="1">1.45 (1.27&#8211;1.66)</td><td rowspan="1" colspan="1">1.42 (0.48&#8211;4.17)</td><td rowspan="1" colspan="1">&#8212;</td></tr><tr><td rowspan="1" colspan="1">&#8195;Case-control studies</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;Current (W: n = 1)</td><td rowspan="1" colspan="1">5.70 (1.51&#8211;21.53)</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">4.25 (3.61&#8211;5.01)</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;Former (W: n = 1; M: n = 1)</td><td rowspan="1" colspan="1">0.49 (0.16&#8211;1.50)</td><td rowspan="1" colspan="1">1.57 (0.61&#8211;4.03)</td><td rowspan="1" colspan="1">1.97 (1.22&#8211;3.18)</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">0.31 (0.07&#8211;1.35)</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;Ever (W: n = 1; M: n = 1)</td><td rowspan="1" colspan="1">2.77 (1.52&#8211;5.04)</td><td rowspan="1" colspan="1">4.54 (2.87&#8211;7.21)</td><td rowspan="1" colspan="1">3.32 (2.07&#8211;5.33)</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">0.61 (0.29&#8211;1.30)</td></tr><tr><td rowspan="1" colspan="1">Hypertension (vs none)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Cohort studies (W: n = 6; M: n = 6)</td><td rowspan="1" colspan="1">2.67 (1.56&#8211;4.56)</td><td rowspan="1" colspan="1">1.78 (1.22&#8211;2.61)</td><td rowspan="1" colspan="1">2.03 (1.56&#8211;2.64)</td><td rowspan="1" colspan="1">1.50 (0.78&#8211;2.89)</td><td rowspan="1" colspan="1">&#8212;</td></tr><tr><td rowspan="1" colspan="1">&#8195;Case-control studies (W: n = 8; M: n = 5)</td><td rowspan="1" colspan="1">2.45 (1.68&#8211;3.58)</td><td rowspan="1" colspan="1">2.99 (2.15&#8211;4.16)</td><td rowspan="1" colspan="1">2.44 (2.07&#8211;2.88)</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">0.82 (0.50&#8211;1.36)</td></tr><tr><td rowspan="1" colspan="1">Alcohol intake (vs none)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Cohort studies</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&lt;150 g/wk (W: n = 4; M: n = 3)</td><td rowspan="1" colspan="1">1.31 (0.94&#8211;1.82)</td><td rowspan="1" colspan="1">1.81 (1.12&#8211;2.92)</td><td rowspan="1" colspan="1">1.45 (1.10&#8211;1.91)</td><td rowspan="1" colspan="1">0.72 (0.40&#8211;1.29)</td><td rowspan="1" colspan="1">&#8212;</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8805;150 g/wk (W: n = 1; M: n = 2)</td><td rowspan="1" colspan="1">1.86 (0.79&#8211;4.40)</td><td rowspan="1" colspan="1">4.02 (1.60&#8211;10.08)</td><td rowspan="1" colspan="1">2.47 (1.44&#8211;4.24)</td><td rowspan="1" colspan="1">0.46 (0.13&#8211;1.63)</td><td rowspan="1" colspan="1">&#8212;</td></tr><tr><td rowspan="1" colspan="1">&#8195;Case-control studies</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&lt;150 g/wk (W: n = 1; M: n = 1)</td><td rowspan="1" colspan="1">0.71 (0.39&#8211;1.28)</td><td rowspan="1" colspan="1">0.78 (0.32&#8211;1.91)</td><td rowspan="1" colspan="1">0.84 (0.69&#8211;1.02)</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">0.91 (0.31&#8211;2.66)</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8805;150 g/wk (M: n = 1)</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">1.48 (0.59&#8211;3.72)</td><td rowspan="1" colspan="1">1.79 (1.29&#8211;2.48)</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td></tr><tr><td rowspan="1" colspan="1">Hypercholesterolemia (vs normal)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Cohort studies (W: n = 1; M: n = 3)</td><td rowspan="1" colspan="1">1.20 (0.64&#8211;2.24)</td><td rowspan="1" colspan="1">1.21 (0.68&#8211;2.18)</td><td rowspan="1" colspan="1">1.24 (0.97&#8211;1.58)</td><td rowspan="1" colspan="1">0.99 (0.42&#8211;2.33)</td><td rowspan="1" colspan="1">&#8212;</td></tr><tr><td rowspan="1" colspan="1">&#8195;Case-control studies</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">0.52 (0.37&#8211;0.75)</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td></tr><tr><td rowspan="1" colspan="1">Regular rigorous physical activity (vs no regular rigorous exercise)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Cohort studies (W: n = 1; M: n = 1)</td><td rowspan="1" colspan="1">0.91 (0.71&#8211;1.16)</td><td rowspan="1" colspan="1">0.27 (0.10&#8211;0.76)</td><td rowspan="1" colspan="1">0.74 (0.53&#8211;1.04)</td><td rowspan="1" colspan="1">3.37 (0.93&#8211;11.60)</td><td rowspan="1" colspan="1">&#8212;</td></tr><tr><td rowspan="1" colspan="1">&#8195;Case-control studies</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">0.69 (0.57&#8211;0.83)</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td></tr><tr><td rowspan="1" colspan="1">Lean BMI &lt;22 (vs &#8805; 22)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Cohort studies (W: n = 2; M: n = 3)</td><td rowspan="1" colspan="1">1.70 (1.13&#8211;2.56)</td><td rowspan="1" colspan="1">1.30 (0.92&#8211;1.84)</td><td rowspan="1" colspan="1">1.31 (1.14&#8211;1.49)</td><td rowspan="1" colspan="1">1.31 (0.76&#8211;2.24)</td><td rowspan="1" colspan="1">&#8212;</td></tr><tr><td rowspan="1" colspan="1">&#8195;Case-control studies (W: n = 1)</td><td rowspan="1" colspan="1">0.74 (0.35&#8211;1.54)</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">1.39 (0.74&#8211;2.58)</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td></tr><tr><td rowspan="1" colspan="1">Diabetes (vs none)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Cohort studies (W: n = 1; M: n = 1)</td><td rowspan="1" colspan="1">0.93 (0.59&#8211;1.47)</td><td rowspan="1" colspan="1">0.82 (0.55&#8211;1.22)</td><td rowspan="1" colspan="1">0.75 (0.55&#8211;1.02)</td><td rowspan="1" colspan="1">1.13 (0.62&#8211;2.08)</td><td rowspan="1" colspan="1">&#8212;</td></tr><tr><td rowspan="1" colspan="1">&#8195;Case-control studies (W: n = 1; M: n = 1)</td><td rowspan="1" colspan="1">0.26 (0.13&#8211;0.52)</td><td rowspan="1" colspan="1">0.55 (0.30&#8211;1.02)</td><td rowspan="1" colspan="1">0.52 (0.41&#8211;0.65)</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">0.47 (0.19&#8211;1.19)</td></tr><tr><td rowspan="1" colspan="1">Oral contraceptive use (vs never)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Cohort studies</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;Current</td><td rowspan="1" colspan="1">5.40 (0.69&#8211;42.57)</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;Former</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td></tr><tr><td rowspan="1" colspan="1">&#8195;Case-control studies</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;Current</td><td rowspan="1" colspan="1">1.78 (0.82&#8211;3.87)</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;Former</td><td rowspan="1" colspan="1">1.35 (0.39&#8211;4.62)</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;Ever</td><td rowspan="1" colspan="1">0.93 (0.61&#8211;1.41)</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td></tr><tr><td rowspan="1" colspan="1">Hormone replacement therapy (vs never)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Cohort studies</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;Current</td><td rowspan="1" colspan="1">1.03 (0.72&#8211;1.48)</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;Former</td><td rowspan="1" colspan="1">1.03 (0.47&#8211;2.25)</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td></tr><tr><td rowspan="1" colspan="1">&#8195;Case-control studies</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;Current</td><td rowspan="1" colspan="1">0.58 (0.29&#8211;1.14)</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;Former</td><td rowspan="1" colspan="1">0.77 (0.44&#8211;1.33)</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">&#8212;</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: ROR = ratio of odds ratio; RRR = ratio of relative risk.</p></fn><fn id="tblfn1"><label>a</label><p>Totals represent pooled estimates from all studies included in the forest plot. For studies that reported risk factors separately for male and female patients, sex-specific estimates were calculated.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3-2-2"><title>Hypertension</title><p>Hypertension was associated with increased aSAH risk in both cohort studies (RR 2.03, 95% CI 1.56&#8211;2.64, <italic toggle="yes">I</italic><sup>2</sup> = 89%, 15 studies, 2,441,026 patients) and case-control studies (OR 2.44, 95% CI 2.07&#8211;2.88, <italic toggle="yes">I</italic><sup>2</sup> = 64%, 27 studies, 8,322,556 patients), but no statistically significant sex-specific association was observed (RRR 1.50, 95% CI 0.78&#8211;2.89; ROR 0.82, 95% CI 0.50&#8211;1.36).</p></sec><sec id="s3-2-3"><title>Alcohol Consumption</title><p>Moderate alcohol consumption (&lt;150 g/wk) (vs no alcohol) was modestly associated with increased aSAH risk in cohort studies (RR 1.45, 95% CI 1.10&#8211;1.91, <italic toggle="yes">I</italic><sup>2</sup> = 1%, 7 studies, 299,443 patients) but not in case-control studies (OR 0.84, 95% CI 0.69&#8211;1.02, <italic toggle="yes">I</italic><sup>2</sup> = 5%, 7 studies, 1,449,394 patients), with no statistically significant sex-specific association (RRR 0.72, 95% CI 0.40&#8211;1.29; ROR 0.91, 95% CI 0.31&#8211;2.66). Excessive alcohol intake (&#8805;150 g/wk) (vs no alcohol) was linked to higher aSAH risk in both cohort studies (RR 2.47, 95% CI 1.44&#8211;4.24, <italic toggle="yes">I</italic><sup>2</sup> = 0%, 4 studies, 196,412 patients) and case-control studies (OR 1.79, 95% CI 1.29&#8211;2.48, <italic toggle="yes">I</italic><sup>2</sup> = 50%, 7 studies, 4,418 patients), again with no statistically significant sex-specific association (RRR 0.46, 95% CI 0.13&#8211;1.63).</p></sec><sec id="s3-2-4"><title>Lean BMI</title><p>Lean BMI (&lt;22) was associated with increased aSAH risk in cohort studies (RR 1.31, 95% CI 1.15&#8211;1.50, <italic toggle="yes">I</italic><sup>2</sup> = 0%, 7 studies, 1,044,285 patients), but not in case-control studies (OR 1.39, 95% CI 0.74&#8211;2.60, <italic toggle="yes">I</italic><sup>2</sup> = 69%, 3 studies, 1,437 patients), with no statistically significant sex-specific association (RRR 1.31, 95% CI 0.76&#8211;2.24).</p></sec><sec id="s3-2-5"><title>Physical Activity</title><p>There was no statistically significant association between regular rigorous physical activity and aSAH risk in cohort studies (RR 0.74, 95% CI 0.53&#8211;1.04, <italic toggle="yes">I</italic><sup>2</sup> = 57%, 5 studies, 1,370,696 patients). However, case-control studies showed a statistically significant association (OR 0.69, 95% CI 0.57&#8211;0.83, <italic toggle="yes">I</italic><sup>2</sup> = 0%, 5 studies, 2,579,908 patients), with no statistically significant sex-specific association (RRR 3.37, 95% CI 0.93&#8211;11.60).</p></sec><sec id="s3-2-6"><title>Diabetes</title><p>There was no statistically significant association between diabetes and aSAH risk in cohort studies (RR 0.75, 95% CI 0.55&#8211;1.02, <italic toggle="yes">I</italic><sup>2</sup> = 19%, 4 studies, 992,545 patients). However, case-control studies showed a statistically significant association (OR 0.52, 95% CI 0.41&#8211;0.65, <italic toggle="yes">I</italic><sup>2</sup> = 21%, 13 studies, 5,371,888 patients), with no statistically significant sex-specific association (RRR 1.13, 95% CI 0.62&#8211;2.08; ROR 0.47, 95% CI 0.19&#8211;1.19).</p></sec><sec id="s3-2-7"><title>Hypercholesterolemia</title><p>Hypercholesterolemia showed inconsistent associations, with a nonstatistically significant increase in risk in cohort studies (RR 1.24, 95% CI 0.97&#8211;1.58, <italic toggle="yes">I</italic><sup>2</sup> = 0%, 5 studies, 245,383 patients), but was associated with a reduced risk in case-control studies (OR 0.52, 95% CI 0.37&#8211;0.74, <italic toggle="yes">I</italic><sup>2</sup> = 60%, 7 studies, 3,065,754 patients). The RRR and ROR did not suggest a sex-specific association.</p></sec><sec id="s3-2-8"><title>Female-Specific Factors: Hormone Replacement Therapy and Oral Contraceptive Use</title><p>Neither current hormone replacement therapy (RR 1.03, 95% CI 0.72&#8211;1.48, <italic toggle="yes">I</italic><sup>2</sup> = 23%, 3 studies, 1,159,991 patients; OR 0.58, 95% CI 0.29&#8211;1.15, <italic toggle="yes">I</italic><sup>2</sup> = 51%, 2 studies, 863 patients) nor current oral contraceptive use (RR 5.40, 95% CI 0.68&#8211;42.57, <italic toggle="yes">I</italic><sup>2</sup> = 0%, 1 study, 17,032 patients; OR 1.78, 95% CI 0.82&#8211;3.87, <italic toggle="yes">I</italic><sup>2</sup> = 49%, 4 studies, 599,979 patients) had a statistically significant association with aSAH risk.</p></sec></sec></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><p>The association between aSAH and current smoking is stronger in female patients than in male patients, whereas associations with hypertension and excessive alcohol are similar for both sexes. Diabetes and regular rigorous physical activity are associated with a reduced risk of aSAH in case-control studies, but this association was not observed in cohort studies. With 35 more studies included compared with the 2005 meta-analysis, findings on regular rigorous exercise are now more consistent and data on diabetes are more reliable. Associations with hypercholesterolemia, lean BMI, and female-specific factors such as hormone replacement therapy and oral contraceptive use remain uncertain because of differences between pooled ORs and RRs, but overall, no statistically significant associations were observed. However, these results should be interpreted with caution because of potential biases, heterogeneity, and limited availability of sex-specific data. There is also variation in the number and type of adjustment factors between studies, including age, as well as a predominance of studies from high-income countries with limited representation from low-income and middle-income countries. Smoking, hypertension, and excessive alcohol consumption remain the most important risk factors of aSAH.</p><p>Our study, with nearly twice as many studies as the 2005 meta-analysis,<sup><xref rid="R3" ref-type="bibr">3</xref></sup> reaffirms smoking, hypertension, and excessive alcohol intake as the most important risk factors and provides more precise estimates. The 2005 meta-analysis reports inconsistent findings for lean BMI and rigorous exercise. Our analysis offers improved insights into these associations: lean BMI is associated with increased risk (although borderline statistically significant in case-control studies), and rigorous exercise is associated with a reduced risk (although borderline statistically significant in cohort studies). The inverse association between diabetes and aSAH risk observed in 2005 is confirmed and now more reliable (previous RR 0.3, 95% CI 0&#8211;2.2; OR 0.7, 95% CI 0.5&#8211;0.8; now RR 0.75, 95% CI 0.55&#8211;1.02; OR 0.52, 95% CI 0.41&#8211;0.65). However, the association with hypercholesterolemia remains inconsistent, with case-control studies suggesting lower risk and cohort studies showing no statistically significant relationship. Unlike the 2005 analysis, our study finds no statistically significant association between hormone replacement therapy and aSAH. A 2019 systematic review and meta-analysis, which focuses on studies specifically examining sex differences, found no sex-specific associations for hypertension and smoking.<sup><xref rid="R5" ref-type="bibr">5</xref></sup> By contrast, our study suggests a potential sex-specific association for hypertension in female participants, although it is not statistically significant. This difference may be due to the exclusion of many studies in the 2019 review that we include because their analysis only considers risk factors stratified by sex or those with an interaction term between sex and aSAH risk factors.</p><p>The observed sex differences in risk factors may be explained by biological, hormonal, and behavioral differences between male and female patients. For instance, female patients might be more susceptible to the vascular effects of smoking. One hypothesis is that smoking lowers estrogen levels, which could influence vascular profiles and partly explain this differential impact. This is especially relevant because the incidence of aSAH in female individuals increases significantly after age 50 compared with male individuals, a time when estrogen levels naturally decline.<sup><xref rid="R4" ref-type="bibr">4</xref></sup></p><p>The association between low BMI and an increased risk of aSAH has also been reported in other studies on hemorrhagic stroke, including ICH and aSAH-specific research.<sup><xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R44" ref-type="bibr">44</xref>,e30-e33</sup> This relationship may be confounded by weight loss associated with high alcohol consumption and smoking.<sup><xref rid="R44" ref-type="bibr">44</xref>,e30,e34,e35</sup> Of the 8 articles describing low BMI included in our meta-analysis, only 4 studies adjusted for alcohol overuse and smoking.</p><p>The strengths of our systematic review and meta-analysis include the large number of studies, encompassing nearly 6,000,000 patients, and the comprehensive evaluation of a wide range of risk factors. We conduct subgroup analyses by study type to assess the impact on effect estimates and heterogeneity, as well as by specific risk factors, such as current, former, and ever smoking. In addition, we provide a detailed risk-of-bias assessment and use funnel plots to address heterogeneity, to better interpret the results.</p><p>Our study also has several limitations that should be considered. First, significant heterogeneity among the included studies hampers interpretation of several pooled effect estimates. This heterogeneity stems from factors such as differences in study design, population characteristics, and methods of aSAH diagnosis. Substantial differences in heterogeneity between cohort and case-control studies for several risk factors suggest that study design plays a key role, although no consistent pattern indicates that 1 design consistently has lower heterogeneity. Second, several sources of bias might be present, including the following: (1) publication bias, suggested by funnel plot asymmetry for several risk factors, indicating a tendency to publish studies with statistically significant findings; (2) selection bias from restricted populations, affecting external validity; (3) information bias due to inconsistent aSAH and risk factor data collection; (4) recall and misclassification biases from varying risk factor definitions; and (5) investigation bias from different evaluation methods, which may lead to discrepancies and inaccurate effect size estimates.</p><p>In addition, we analyze only 1 risk factor at a time, potentially overlooking interrelationships and cumulative effects of multiple risk factors, which may lead to underestimating their combined impact on aSAH risk. Individuals with multiple risk factors are often at a higher risk, but this was not assessed in our analysis. Furthermore, we analyze risk factors dichotomously (e.g., hypertension yes/no and smoking current/former/never), which limits our ability to capture differences in exposure levels. For example, male patients may smoke more heavily than female patients, but our analysis treats them equally.<sup>e36,e37</sup></p><p>In addition, not all studies account for age or other residual confounding factors, with considerable variation in adjustments used, complicating reliability. Third, although 67 studies are included, the number of studies available for some risk factors, such as oral contraceptive use, hormone replacement therapy, and lean BMI, is too small for robust conclusions. In addition, most studies do not report data separately by sex, limiting sex-specific analyses and underscoring the need for future research. Furthermore, race-related and ethnicity-related differences were not evaluated, which could moderate these findings. Fourth, some studies combine risk factors or use reference categories that do not fit our classification system, making them ineligible for inclusion in the meta-analysis.<sup><xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R34" ref-type="bibr">34</xref>,<xref rid="R38" ref-type="bibr">38</xref>,<xref rid="R48" ref-type="bibr">48</xref>,<xref rid="R49" ref-type="bibr">49</xref>,e17,e29</sup> Furthermore, changes in oral contraceptive dosages over time&#8212;such as the shift from high-dose to low-dose formulations&#8212;could not be accounted for because most studies lacked dosage-specific data. This may affect the interpretation of findings on exogenous estrogen exposure. Fifth, most studies provided both crude and adjusted data on risk factors. When adjusted estimates were unavailable, crude estimates were pooled with adjusted ones. This approach may have introduced bias because crude estimates do not account for confounding factors.</p><p>Female patients have a statistically significant stronger association with current smoking, suggesting that targeted prevention efforts may be particularly beneficial for this group. Because smoking, hypertension, and excessive alcohol consumption remain the most important risk factors of aSAH, information on these&#8212;including the sex-specific effect of smoking&#8212;should be incorporated into risk assessments, such as the PHASES score, to guide prevention strategies and improve risk management.<sup>e38</sup> Regular rigorous exercise and diabetes are associated with a reduced risk of aSAH, whereas the associations with lean BMI, hypercholesterolemia, and female-specific factors such as hormone replacement therapy and oral contraceptive use remain unclear because of inconsistent findings. Because the sex-specific risk of smoking alone does not fully explain the higher incidence of aSAH in female patients, large-scale studies are needed to clarify the role of female-specific factors in aSAH.</p></sec></body><back><sec sec-type="contributions"><title>Author Contributions</title><p content-type="contributions">M. Ali: drafting/revision of the manuscript for content, including medical writing for content; major role in the acquisition of data; study concept or design; analysis or interpretation of data. M.J.A. van Eldik: drafting/revision of the manuscript for content, including medical writing for content; major role in the acquisition of data; analysis or interpretation of data. S. Rietkerken: major role in the acquisition of data. J.W. Schoones: drafting/revision of the manuscript for content, including medical writing for content; major role in the acquisition of data. N.D. Kruyt: drafting/revision of the manuscript for content, including medical writing for content; analysis or interpretation of data. G.J.E. Rinkel: drafting/revision of the manuscript for content, including medical writing for content; analysis or interpretation of data. M.J.H. Wermer: drafting/revision of the manuscript for content, including medical writing for content; study concept or design; analysis or interpretation of data. S. Peters: drafting/revision of the manuscript for content, including medical writing for content; analysis or interpretation of data. Y.M. Ruigrok: drafting/revision of the manuscript for content, including medical writing for content; major role in the acquisition of data; study concept or design; analysis or interpretation of data.</p></sec><sec sec-type="funding"><title>Study Funding</title><p content-type="funding">Y.M. Ruigrok received funding from the Dutch Heart Foundation (Dekker grant 03-001-2022-0157) and the European Research Council under the European Union's Horizon 2020 research and innovation program (grant agreement 852173). M.J.H. Wermer is supported by a VIDI and Aspasia grant from ZonMw (91717337). S.A.E. Peters is supported by a VIDI from ZonMw (09150172010050).</p></sec><sec sec-type="COI-statement"><title>Disclosure</title><p>The authors report no relevant disclosures. Go to <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://n.neurology.org/lookup/doi/10.1212/WNL.0000000000213511" ext-link-type="uri">Neurology.org/N</ext-link> for full disclosures.</p></sec><glossary><title>Glossary</title><def-list><def-item><term id="G1">aSAH</term><def><p>aneurysmal subarachnoid hemorrhage</p></def></def-item><def-item><term id="G2">BMI</term><def><p>body mass index</p></def></def-item><def-item><term id="G3">HR</term><def><p>hazard ratio</p></def></def-item><def-item><term id="G4">ICD</term><def><p>International Classification of Diseases</p></def></def-item><def-item><term id="G5">OR</term><def><p>odds ratio</p></def></def-item><def-item><term id="G6">ROR</term><def><p>ratio of OR</p></def></def-item><def-item><term id="G7">RR</term><def><p>relative risk</p></def></def-item><def-item><term id="G8">RRR</term><def><p>ratio of RR</p></def></def-item><def-item><term id="G9">SE</term><def><p>standard error</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="R1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Claassen</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Park</surname><given-names>S</given-names></string-name></person-group>. <article-title>Spontaneous subarachnoid haemorrhage</article-title>. <source>Lancet</source>. <year>2022</year>;<volume>400</volume>(<issue>10355</issue>):<fpage>846</fpage>-<lpage>862</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(22)00938-2</pub-id><pub-id pub-id-type="pmid">35985353</pub-id><pub-id pub-id-type="pmcid">PMC9987649</pub-id></mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Vlak</surname><given-names>MH</given-names></string-name>, <string-name name-style="western"><surname>Algra</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Brandenburg</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Rinkel</surname><given-names>GJ</given-names></string-name></person-group>. <article-title>Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis</article-title>. <source>Lancet Neurol</source>. <year>2011</year>;<volume>10</volume>(<issue>7</issue>):<fpage>626</fpage>-<lpage>636</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1474-4422(11)70109-0</pub-id><pub-id pub-id-type="pmid">21641282</pub-id></mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Feigin</surname><given-names>VL</given-names></string-name>, <string-name name-style="western"><surname>Rinkel</surname><given-names>GJ</given-names></string-name>, <string-name name-style="western"><surname>Lawes</surname><given-names>CM</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies</article-title>. <source>Stroke</source>. <year>2005</year>;<volume>36</volume>(<issue>12</issue>):<fpage>2773</fpage>-<lpage>2780</lpage>. doi:<pub-id pub-id-type="doi">10.1161/01.STR.0000190838.02954.e8</pub-id><pub-id pub-id-type="pmid">16282541</pub-id></mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ali</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>van Etten</surname><given-names>ES</given-names></string-name>, <string-name name-style="western"><surname>Akoudad</surname><given-names>S</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Haemorrhagic stroke and brain vascular malformations in women: risk factors and clinical features</article-title>. <source>Lancet Neurol</source>. <year>2024</year>;<volume>23</volume>(<issue>6</issue>):<fpage>625</fpage>-<lpage>635</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1474-4422(24)00122-4</pub-id><pub-id pub-id-type="pmid">38760100</pub-id></mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Rehman</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Sahle</surname><given-names>BW</given-names></string-name>, <string-name name-style="western"><surname>Chandra</surname><given-names>RV</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Sex differences in risk factors for aneurysmal subarachnoid haemorrhage: systematic review and meta-analysis</article-title>. <source>J Neurol Sci</source>. <year>2019</year>;<volume>406</volume>:<fpage>116446</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jns.2019.116446</pub-id><pub-id pub-id-type="pmid">31521957</pub-id></mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sundstr&#246;m</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>S&#246;derholm</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>S&#246;derberg</surname><given-names>S</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Risk factors for subarachnoid haemorrhage: a nationwide cohort of 950 000 adults</article-title>. <source>Int J Epidemiol</source>. <year>2019</year>;<volume>48</volume>(<issue>6</issue>):<fpage>2018</fpage>-<lpage>2025</lpage>. doi:<pub-id pub-id-type="doi">10.1093/ije/dyz163</pub-id><pub-id pub-id-type="pmid">31363756</pub-id></mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Inagawa</surname><given-names>T</given-names></string-name></person-group>. <article-title>Risk factors for the formation and rupture of intracranial saccular aneurysms in Shimane, Japan</article-title>. <source>World Neurosurg</source>. <year>2010</year>;<volume>73</volume>(<issue>3</issue>):<fpage>155</fpage>-<lpage>164</lpage>; discussion e123. doi:<pub-id pub-id-type="doi">10.1016/j.surneu.2009.03.007</pub-id><pub-id pub-id-type="pmid">20860953</pub-id></mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Knekt</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Reunanen</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Aho</surname><given-names>K</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Risk factors for subarachnoid hemorrhage in a longitudinal population study</article-title>. <source>J Clin Epidemiol</source>. <year>1991</year>;<volume>44</volume>(<issue>9</issue>):<fpage>933</fpage>-<lpage>939</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0895-4356(91)90056-f</pub-id><pub-id pub-id-type="pmid">1890435</pub-id></mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Suh</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Jee</surname><given-names>SH</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>HC</given-names></string-name>, <string-name name-style="western"><surname>Nam</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>IS</given-names></string-name>, <string-name name-style="western"><surname>Appel</surname><given-names>LJ</given-names></string-name></person-group>. <article-title>Low serum cholesterol and haemorrhagic stroke in men: Korea Medical Insurance Corporation Study</article-title>. <source>Lancet</source>. <year>2001</year>;<volume>357</volume>(<issue>9260</issue>):<fpage>922</fpage>-<lpage>925</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(00)04213-6</pub-id><pub-id pub-id-type="pmid">11289349</pub-id></mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Moher</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Liberati</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Tetzlaff</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Altman</surname><given-names>DG</given-names></string-name></person-group>; <collab>PRISMA Group</collab>. <article-title>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement</article-title>. <source>PLoS Med</source>. <year>2009</year>;<volume>6</volume>(<issue>7</issue>):<fpage>e1000097</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pmed.1000097</pub-id><pub-id pub-id-type="pmid">19621072</pub-id><pub-id pub-id-type="pmcid">PMC2707599</pub-id></mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><string-name name-style="western"><surname>Wells</surname><given-names>GA</given-names></string-name>, <string-name name-style="western"><surname>Shea</surname><given-names>BJ</given-names></string-name>, <string-name name-style="western"><surname>O'Connell</surname><given-names>D</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses [online]</article-title>. <comment>Ottawa Health Research Institute Web. 2014;7. Accessed March 10, 2025. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp" ext-link-type="uri">http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp</ext-link></comment>.</mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Higgins</surname><given-names>JP</given-names></string-name>, <string-name name-style="western"><surname>Thompson</surname><given-names>SG</given-names></string-name></person-group>. <article-title>Quantifying heterogeneity in a meta-analysis</article-title>. <source>Stat Med</source>. <year>2002</year>;<volume>21</volume>(<issue>11</issue>):<fpage>1539</fpage>-<lpage>1558</lpage>. doi:<pub-id pub-id-type="doi">10.1002/sim.1186</pub-id><pub-id pub-id-type="pmid">12111919</pub-id></mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Tokuda</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Stein</surname><given-names>GH</given-names></string-name></person-group>. <article-title>Serum lipids as protective factors for subarachnoid hemorrhage</article-title>. <source>J Clin Neurosci</source>. <year>2005</year>;<volume>12</volume>(<issue>5</issue>):<fpage>538</fpage>-<lpage>541</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jocn.2004.07.021</pub-id><pub-id pub-id-type="pmid">15975790</pub-id></mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Cui</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Iso</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Toyoshima</surname><given-names>H</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Serum total cholesterol levels and risk of mortality from stroke and coronary heart disease in Japanese: the JACC study</article-title>. <source>Atherosclerosis</source>. <year>2007</year>;<volume>194</volume>(<issue>2</issue>):<fpage>415</fpage>-<lpage>420</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2006.08.022</pub-id><pub-id pub-id-type="pmid">16970954</pub-id></mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Okamoto</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Horisawa</surname><given-names>R</given-names></string-name></person-group>. <article-title>The joint effect of oxidative stress and antioxidants on the risk of an aneurysmal rupture subarachnoid hemorrhage: a case-control study in Japan</article-title>. <source>Ann Epidemiol</source>. <year>2007</year>;<volume>17</volume>(<issue>5</issue>):<fpage>359</fpage>-<lpage>363</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.annepidem.2006.12.001</pub-id><pub-id pub-id-type="pmid">17462545</pub-id></mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Jim&#233;nez-Yepes</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Londo&#241;o-Fern&#225;ndez</surname><given-names>JL</given-names></string-name></person-group>. <article-title>Risk of aneurysmal subarachnoid hemorrhage: the role of confirmed hypertension</article-title>. <source>Stroke</source>. <year>2008</year>;<volume>39</volume>(<issue>4</issue>):<fpage>1344</fpage>-<lpage>1346</lpage>. doi:<pub-id pub-id-type="doi">10.1161/STROKEAHA.107.504019</pub-id><pub-id pub-id-type="pmid">18309146</pub-id></mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Adamski</surname><given-names>MG</given-names></string-name>, <string-name name-style="western"><surname>Borratynska</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Krupa</surname><given-names>M</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>A1/A2 polymorphism of GpIIIa gene and a risk of aneurysmal subarachnoid haemorrhage</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2009</year>;<volume>383</volume>(<issue>2</issue>):<fpage>228</fpage>-<lpage>230</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbrc.2009.03.156</pub-id><pub-id pub-id-type="pmid">19345676</pub-id></mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ruiz-Sandoval</surname><given-names>JL</given-names></string-name>, <string-name name-style="western"><surname>Cant&#250;</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Chiquete</surname><given-names>E</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Aneurysmal subarachnoid hemorrhage in a Mexican multicenter registry of cerebrovascular disease: the RENAMEVASC study</article-title>. <source>J Stroke Cerebrovasc Dis</source>. <year>2009</year>;<volume>18</volume>(<issue>1</issue>):<fpage>48</fpage>-<lpage>55</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jstrokecerebrovasdis.2008.09.019</pub-id><pub-id pub-id-type="pmid">19110145</pub-id></mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Koshy</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Easwer</surname><given-names>HV</given-names></string-name>, <string-name name-style="western"><surname>Premkumar</surname><given-names>S</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Risk factors for aneurysmal subarachnoid hemorrhage in an Indian population</article-title>. <source>Cerebrovasc Dis</source>. <year>2010</year>;<volume>29</volume>(<issue>3</issue>):<fpage>268</fpage>-<lpage>274</lpage>. doi:<pub-id pub-id-type="doi">10.1159/000275501</pub-id><pub-id pub-id-type="pmid">20090318</pub-id></mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kim</surname><given-names>CK</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>BJ</given-names></string-name>, <string-name name-style="western"><surname>Ryu</surname><given-names>WS</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>SH</given-names></string-name>, <string-name name-style="western"><surname>Yoon</surname><given-names>BW</given-names></string-name></person-group>. <article-title>Impact of smoking cessation on the risk of subarachnoid haemorrhage: a nationwide multicentre case control study</article-title>. <source>J Neurol Neurosurg Psychiatry</source>. <year>2012</year>;<volume>83</volume>(<issue>11</issue>):<fpage>1100</fpage>-<lpage>1103</lpage>. doi:<pub-id pub-id-type="doi">10.1136/jnnp-2012-302538</pub-id><pub-id pub-id-type="pmid">22935539</pub-id></mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Shiue</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Arima</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Hankey</surname><given-names>GJ</given-names></string-name>, <string-name name-style="western"><surname>Anderson</surname><given-names>CS</given-names></string-name></person-group>; <collab>ACROSS Group</collab>. <article-title>Modifiable lifestyle behaviours account for most cases of subarachnoid haemorrhage: a population-based case-control study in Australasia</article-title>. <source>J Neurol Sci</source>. <year>2012</year>;<volume>313</volume>(<issue>1-2</issue>):<fpage>92</fpage>-<lpage>94</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jns.2011.09.017</pub-id><pub-id pub-id-type="pmid">21996272</pub-id></mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Alaqeel</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Almasri</surname><given-names>SH</given-names></string-name>, <string-name name-style="western"><surname>Alotaibi</surname><given-names>NM</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Prevalence of symptoms and risk of sleep apnea in patients with ruptured cerebral aneurysm</article-title>. <source>Neurosciences (Riyadh)</source>. <year>2013</year>;<volume>18</volume>(<issue>3</issue>):<fpage>248</fpage>-<lpage>251</lpage>.<pub-id pub-id-type="pmid">23887215</pub-id></mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Vlak</surname><given-names>MH</given-names></string-name>, <string-name name-style="western"><surname>Rinkel</surname><given-names>GJ</given-names></string-name>, <string-name name-style="western"><surname>Greebe</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Greving</surname><given-names>JP</given-names></string-name>, <string-name name-style="western"><surname>Algra</surname><given-names>A</given-names></string-name></person-group>. <article-title>Lifetime risks for aneurysmal subarachnoid haemorrhage: multivariable risk stratification</article-title>. <source>J Neurol Neurosurg Psychiatry</source>. <year>2013</year>;<volume>84</volume>(<issue>6</issue>):<fpage>619</fpage>-<lpage>623</lpage>. doi:<pub-id pub-id-type="doi">10.1136/jnnp-2012-303783</pub-id><pub-id pub-id-type="pmid">23355806</pub-id></mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Huang</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>Q</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Association between circular RNAs and intracranial aneurysm rupture under the synergistic effect of individual environmental factors</article-title>. <source>Front Neurol</source>. <year>2021</year>;<volume>12</volume>:<fpage>594835</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fneur.2021.594835</pub-id><pub-id pub-id-type="pmid">33746870</pub-id><pub-id pub-id-type="pmcid">PMC7969784</pub-id></mixed-citation></ref><ref id="R25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Missori</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>de Sousa</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>Ambrosone</surname><given-names>A</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Cotinine levels influence the risk of rupture of brain aneurysms</article-title>. <source>Acta Neurol Scand</source>. <year>2022</year>;<volume>146</volume>(<issue>5</issue>):<fpage>562</fpage>-<lpage>567</lpage>. doi:<pub-id pub-id-type="doi">10.1111/ane.13679</pub-id><pub-id pub-id-type="pmid">35920037</pub-id><pub-id pub-id-type="pmcid">PMC9805191</pub-id></mixed-citation></ref><ref id="R26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ok</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Jeon</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Heo</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>J</given-names></string-name></person-group>. <article-title>Effect of smoking cessation on the risk of subarachnoid hemorrhage: a nested case-control study in Korean men</article-title>. <source>Stroke</source>. <year>2023</year>;<volume>54</volume>(<issue>12</issue>):<fpage>3012</fpage>-<lpage>3020</lpage>. doi:<pub-id pub-id-type="doi">10.1161/STROKEAHA.123.044969</pub-id><pub-id pub-id-type="pmid">37909203</pub-id></mixed-citation></ref><ref id="R27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Arima</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Tanizaki</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Yonemoto</surname><given-names>K</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Impact of blood pressure levels on different types of stroke: the Hisayama study</article-title>. <source>J Hypertens</source>. <year>2009</year>;<volume>27</volume>(<issue>12</issue>):<fpage>2437</fpage>-<lpage>2443</lpage>. doi:<pub-id pub-id-type="doi">10.1097/HJH.0b013e328330e882</pub-id><pub-id pub-id-type="pmid">19657282</pub-id></mixed-citation></ref><ref id="R28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sandvei</surname><given-names>MS</given-names></string-name>, <string-name name-style="western"><surname>Romundstad</surname><given-names>PR</given-names></string-name>, <string-name name-style="western"><surname>M&#252;ller</surname><given-names>TB</given-names></string-name>, <string-name name-style="western"><surname>Vatten</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Vik</surname><given-names>A</given-names></string-name></person-group>. <article-title>Risk factors for aneurysmal subarachnoid hemorrhage in a prospective population study: the HUNT study in Norway</article-title>. <source>Stroke</source>. <year>2009</year>;<volume>40</volume>(<issue>6</issue>):<fpage>1958</fpage>-<lpage>1962</lpage>. doi:<pub-id pub-id-type="doi">10.1161/STROKEAHA.108.539544</pub-id><pub-id pub-id-type="pmid">19228833</pub-id></mixed-citation></ref><ref id="R29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hata</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Doi</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Ninomiya</surname><given-names>T</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Combined effects of smoking and hypercholesterolemia on the risk of stroke and coronary heart disease in Japanese: the Hisayama study</article-title>. <source>Cerebrovasc Dis</source>. <year>2011</year>;<volume>31</volume>(<issue>5</issue>):<fpage>477</fpage>-<lpage>484</lpage>. doi:<pub-id pub-id-type="doi">10.1159/000324392</pub-id><pub-id pub-id-type="pmid">21358199</pub-id></mixed-citation></ref><ref id="R30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lindekleiv</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Sandvei</surname><given-names>MS</given-names></string-name>, <string-name name-style="western"><surname>Nj&#248;lstad</surname><given-names>I</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Sex differences in risk factors for aneurysmal subarachnoid hemorrhage: a cohort study</article-title>. <source>Neurology</source>. <year>2011</year>;<volume>76</volume>(<issue>7</issue>):<fpage>637</fpage>-<lpage>643</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.0b013e31820c30d3</pub-id><pub-id pub-id-type="pmid">21321337</pub-id></mixed-citation></ref><ref id="R31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Tuomilehto</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Jousilahti</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Antikainen</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>G</given-names></string-name></person-group>. <article-title>Total and high-density lipoprotein cholesterol and stroke risk</article-title>. <source>Stroke</source>. <year>2012</year>;<volume>43</volume>(<issue>7</issue>):<fpage>1768</fpage>-<lpage>1774</lpage>. doi:<pub-id pub-id-type="doi">10.1161/STROKEAHA.111.646778</pub-id><pub-id pub-id-type="pmid">22496337</pub-id></mixed-citation></ref><ref id="R32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ikehara</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Iso</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Yamagishi</surname><given-names>K</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Alcohol consumption and risk of stroke and coronary heart disease among Japanese women: the Japan Public Health Center-based prospective study</article-title>. <source>Prev Med</source>. <year>2013</year>;<volume>57</volume>(<issue>5</issue>):<fpage>505</fpage>-<lpage>510</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ypmed.2013.07.003</pub-id><pub-id pub-id-type="pmid">23859928</pub-id></mixed-citation></ref><ref id="R33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Korja</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Silventoinen</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Laatikainen</surname><given-names>T</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Risk factors and their combined effects on the incidence rate of subarachnoid hemorrhage: a population-based cohort study</article-title>. <source>PLoS One</source>. <year>2013</year>;<volume>8</volume>(<issue>9</issue>):<fpage>e73760</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0073760</pub-id><pub-id pub-id-type="pmid">24040058</pub-id><pub-id pub-id-type="pmcid">PMC3767622</pub-id></mixed-citation></ref><ref id="R34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Zhang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Arima</surname><given-names>H</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Incidence and risks of subarachnoid hemorrhage in China</article-title>. <source>Stroke</source>. <year>2013</year>;<volume>44</volume>(<issue>10</issue>):<fpage>2891</fpage>-<lpage>2893</lpage>. doi:<pub-id pub-id-type="doi">10.1161/STROKEAHA.113.002599</pub-id><pub-id pub-id-type="pmid">23899918</pub-id></mixed-citation></ref><ref id="R35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Armstrong</surname><given-names>ME</given-names></string-name>, <string-name name-style="western"><surname>Green</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Reeves</surname><given-names>GK</given-names></string-name>, <string-name name-style="western"><surname>Beral</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Cairns</surname><given-names>BJ</given-names></string-name></person-group>; <collab>Million Women Study Collaborators</collab>. <article-title>Frequent physical activity may not reduce vascular disease risk as much as moderate activity: large prospective study of women in the United Kingdom</article-title>. <source>Circulation</source>. <year>2015</year>;<volume>131</volume>(<issue>8</issue>):<fpage>721</fpage>-<lpage>729</lpage>. doi:<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.114.010296</pub-id><pub-id pub-id-type="pmid">25688148</pub-id></mixed-citation></ref><ref id="R36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Pujades-Rodriguez</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>George</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Shah</surname><given-names>AD</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Heterogeneous associations between smoking and a wide range of initial presentations of cardiovascular disease in 1937360 people in England: lifetime risks and implications for risk prediction</article-title>. <source>Int J Epidemiol</source>. <year>2015</year>;<volume>44</volume>(<issue>1</issue>):<fpage>129</fpage>-<lpage>141</lpage>. doi:<pub-id pub-id-type="doi">10.1093/ije/dyu218</pub-id><pub-id pub-id-type="pmid">25416721</pub-id><pub-id pub-id-type="pmcid">PMC4339760</pub-id></mixed-citation></ref><ref id="R37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Shah</surname><given-names>AD</given-names></string-name>, <string-name name-style="western"><surname>Langenberg</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Rapsomaniki</surname><given-names>E</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1&#183;9 million people</article-title>. <source>Lancet Diabetes Endocrinol</source>. <year>2015</year>;<volume>3</volume>:<fpage>105</fpage>-<lpage>113</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S2213-8587(14)70219-0</pub-id><pub-id pub-id-type="pmid">25466521</pub-id><pub-id pub-id-type="pmcid">PMC4303913</pub-id></mixed-citation></ref><ref id="R38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Qureshi</surname><given-names>AI</given-names></string-name>, <string-name name-style="western"><surname>Malik</surname><given-names>AA</given-names></string-name>, <string-name name-style="western"><surname>Saeed</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Defillo</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Sherr</surname><given-names>GT</given-names></string-name>, <string-name name-style="western"><surname>Suri</surname><given-names>MF</given-names></string-name></person-group>. <article-title>Hormone replacement therapy and the risk of subarachnoid hemorrhage in postmenopausal women</article-title>. <source>J Neurosurg</source>. <year>2016</year>;<volume>124</volume>(<issue>1</issue>):<fpage>45</fpage>-<lpage>50</lpage>. doi:<pub-id pub-id-type="doi">10.3171/2014.12.JNS142329</pub-id><pub-id pub-id-type="pmid">26162033</pub-id></mixed-citation></ref><ref id="R39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kubota</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Iso</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Yamagishi</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Sawada</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Tsugane</surname><given-names>S</given-names></string-name></person-group>; <collab>JPHC Study Group</collab>. <article-title>Daily total physical activity and incident stroke: the Japan public health center-based prospective study</article-title>. <source>Stroke</source>. <year>2017</year>;<volume>48</volume>(<issue>7</issue>):<fpage>1730</fpage>-<lpage>1736</lpage>. doi:<pub-id pub-id-type="doi">10.1161/STROKEAHA.117.017560</pub-id><pub-id pub-id-type="pmid">28584003</pub-id></mixed-citation></ref><ref id="R40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>L&#248;kkegaard</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Nielsen</surname><given-names>LH</given-names></string-name>, <string-name name-style="western"><surname>Keiding</surname><given-names>N</given-names></string-name></person-group>. <article-title>Risk of stroke with various types of menopausal hormone therapies: a national cohort study</article-title>. <source>Stroke</source>. <year>2017</year>;<volume>48</volume>(<issue>8</issue>):<fpage>2266</fpage>-<lpage>2269</lpage>. doi:<pub-id pub-id-type="doi">10.1161/STROKEAHA.117.017132</pub-id><pub-id pub-id-type="pmid">28626058</pub-id></mixed-citation></ref><ref id="R41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Rist</surname><given-names>PM</given-names></string-name>, <string-name name-style="western"><surname>Buring</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Ridker</surname><given-names>PM</given-names></string-name>, <string-name name-style="western"><surname>Kase</surname><given-names>CS</given-names></string-name>, <string-name name-style="western"><surname>Kurth</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Rexrode</surname><given-names>KM</given-names></string-name></person-group>. <article-title>Lipid levels and the risk of hemorrhagic stroke among women</article-title>. <source>Neurology</source>. <year>2019</year>;<volume>92</volume>(<issue>19</issue>):<fpage>e2286</fpage>-<lpage>e2294</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.0000000000007454</pub-id><pub-id pub-id-type="pmid">30971484</pub-id><pub-id pub-id-type="pmcid">PMC6537127</pub-id></mixed-citation></ref><ref id="R42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Acosta</surname><given-names>JN</given-names></string-name>, <string-name name-style="western"><surname>Szejko</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Both</surname><given-names>CP</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Genetically determined smoking behavior and risk of nontraumatic subarachnoid hemorrhage</article-title>. <source>Stroke</source>. <year>2021</year>;<volume>52</volume>(<issue>2</issue>):<fpage>582</fpage>-<lpage>587</lpage>. doi:<pub-id pub-id-type="doi">10.1161/STROKEAHA.120.031622</pub-id><pub-id pub-id-type="pmid">33440997</pub-id><pub-id pub-id-type="pmcid">PMC7856108</pub-id></mixed-citation></ref><ref id="R43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>MacDonald</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Madika</surname><given-names>AL</given-names></string-name>, <string-name name-style="western"><surname>Gomes</surname><given-names>R</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Physical activity and stroke among women: a non-linear relationship</article-title>. <source>Prev Med</source>. <year>2021</year>;<volume>150</volume>:<fpage>106485</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ypmed.2021.106485</pub-id><pub-id pub-id-type="pmid">33647351</pub-id></mixed-citation></ref><ref id="R44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Rautalin</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Kaprio</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Ingebrigtsen</surname><given-names>T</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Obesity does not protect from subarachnoid hemorrhage: pooled analyses of 3 large prospective nordic cohorts</article-title>. <source>Stroke</source>. <year>2022</year>;<volume>53</volume>(<issue>4</issue>):<fpage>1301</fpage>-<lpage>1309</lpage>. doi:<pub-id pub-id-type="doi">10.1161/STROKEAHA.121.034782</pub-id><pub-id pub-id-type="pmid">34753302</pub-id><pub-id pub-id-type="pmcid">PMC10510796</pub-id></mixed-citation></ref><ref id="R45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sato</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Nakamura</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Kayaba</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Ishikawa</surname><given-names>S</given-names></string-name></person-group>. <article-title>Stroke risk due to smoking characterized by sex differences in Japan: the Jichi Medical School Cohort Study</article-title>. <source>J Stroke Cerebrovasc Dis</source>. <year>2022</year>;<volume>31</volume>(<issue>2</issue>):<fpage>106203</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jstrokecerebrovasdis.2021.106203</pub-id><pub-id pub-id-type="pmid">34871904</pub-id></mixed-citation></ref><ref id="R46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ewbank</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Gaastra</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Hall</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Galea</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Bulters</surname><given-names>D</given-names></string-name></person-group>. <article-title>Risk of subarachnoid haemorrhage reduces with blood pressure values below hypertensive thresholds</article-title>. <source>Eur J Neurol</source>. <year>2024</year>;<volume>31</volume>(<issue>1</issue>):<fpage>e16105</fpage>. doi:<pub-id pub-id-type="doi">10.1111/ene.16105</pub-id><pub-id pub-id-type="pmid">37877683</pub-id><pub-id pub-id-type="pmcid">PMC11236026</pub-id></mixed-citation></ref><ref id="R47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Yatsuya</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Yamagishi</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>Y</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Risk and population attributable fraction of stroke subtypes in Japan</article-title>. <source>J Epidemiol</source>. <year>2024</year>;<volume>34</volume>(<issue>5</issue>):<fpage>211</fpage>-<lpage>217</lpage>. doi:<pub-id pub-id-type="doi">10.2188/jea.JE20220364</pub-id><pub-id pub-id-type="pmid">37460296</pub-id><pub-id pub-id-type="pmcid">PMC10999523</pub-id></mixed-citation></ref><ref id="R48"><label>48.</label><mixed-citation publication-type="journal"><article-title>Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception</article-title>. <source>Lancet</source>. <year>1996</year>;<volume>348</volume>(<issue>9026</issue>):<fpage>505</fpage>-<lpage>510</lpage>.<pub-id pub-id-type="pmid">8757152</pub-id></mixed-citation></ref><ref id="R49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Fogelholm</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Murros</surname><given-names>K</given-names></string-name></person-group>. <article-title>Cigarette smoking and subarachnoid haemorrhage: a population-based case-control study</article-title>. <source>J Neurol Neurosurg Psychiatry</source>. <year>1987</year>;<volume>50</volume>(<issue>1</issue>):<fpage>78</fpage>-<lpage>80</lpage>. doi:<pub-id pub-id-type="doi">10.1136/jnnp.50.1.78</pub-id><pub-id pub-id-type="pmid">3819759</pub-id><pub-id pub-id-type="pmcid">PMC1033253</pub-id></mixed-citation></ref><ref id="R50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Donahue</surname><given-names>RP</given-names></string-name>, <string-name name-style="western"><surname>Abbott</surname><given-names>RD</given-names></string-name>, <string-name name-style="western"><surname>Reed</surname><given-names>DM</given-names></string-name>, <string-name name-style="western"><surname>Yano</surname><given-names>K</given-names></string-name></person-group>. <article-title>Alcohol and hemorrhagic stroke. The Honolulu Heart program</article-title>. <source>JAMA</source>. <year>1986</year>;<volume>255</volume>(<issue>17</issue>):<fpage>2311</fpage>-<lpage>2314</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.1986.03370170075038</pub-id><pub-id pub-id-type="pmid">3959320</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>